A low-glycemic index meal and bedtime snack prevents postprandial hyperglycemia and associated rises in inflammatory markers, providing protection from early but not late nocturnal hypoglycemia following evening exercise in type 1 diabetes. by Campbell, Matthew et al.
Citation:  Campbell,  Matthew,  Walker,  Mark,  Trenell,  Michael,  Stevenson,  Emma,  Turner, 
Daniel, Bracken, Richard, Shaw, James and West, Dan (2014) A low-glycemic index meal 
and  bedtime  snack  prevents  postprandial  hyperglycemia  and  associated  rises  in 
inflammatory markers, providing protection from early but not late nocturnal hypoglycemia 
following evening exercise in type 1 diabetes. Diabetes care, 37 (7). pp. 1845-1853. ISSN 
1935-5548 
Published by: American Diabetes Association
URL: http://dx.doi.org/10.2337/dc14-0186 <http://dx.doi.org/10.2337/dc14-0186>
This  version  was  downloaded  from  Northumbria  Research  Link: 
http://nrl.northumbria.ac.uk/16390/
Northumbria University has developed Northumbria Research Link (NRL) to enable users to 
access the University’s research output. Copyright © and moral rights for items on NRL are 
retained by the individual author(s) and/or other copyright owners.  Single copies of full items 
can be reproduced,  displayed or  performed,  and given to  third parties in  any format  or 
medium for personal research or study, educational, or not-for-profit purposes without prior 
permission or charge, provided the authors, title and full bibliographic details are given, as 
well  as a hyperlink and/or URL to the original metadata page. The content must  not  be 
changed in any way. Full items must not be sold commercially in any format or medium 
without  formal  permission  of  the  copyright  holder.   The  full  policy  is  available  online: 
http://nrl.northumbria.ac.uk/policies.html
This document may differ from the final, published version of the research and has been 
made available online in accordance with publisher policies. To read and/or cite from the 
published version of the research, please visit the publisher’s website (a subscription may be 
required.)
TITLE: A low glycemic index meal and bedtime snack prevents post-prandial hyperglycemia and 
associated rises in inflammatory markers, providing protection from early but not late nocturnal 
hypoglycemia following evening exercise in type 1 diabetes 
 
 
Author 
Matthew D Campbell
1 
BSc, Mark Walker
2
 MD, Michael I Trenell
2
 PhD, Emma J Stevenson
1
 PhD, 
Daniel Turner
3 
BSc, Richard M Bracken
3
 PhD, James A Shaw
2 
FRCP, Daniel J West
1
 PhD. 
Affiliation 
1
Faculty of Health and Life Sciences, Northumbria University, Newcastle-upon-Tyne, UK; 
2
Institute of 
Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, UK; 
3
Applied Sports, Technology, 
Exercise and Medicine Research Centre, College of Engineering, Swansea University, Swansea, UK 
 
Corresponding author 
Daniel J West 
Faculty of Health and Life Sciences, Northumberland Building, Northumbria University, Northumberland 
Road, Newcastle-upon-Tyne, NE1 8ST, UK. 
Tel: 0044+ (0)191 243 7086 
Email: d.j.west@northumbria.ac.uk 
 
Running title: Glycaemic index of post-exercise foodstuffs 
Clinical trials number: NCT01794650, ClinicalTrials.gov 
Word count: abstract 249, manuscript 3798 
No. of tables/figures: 3 Figures, 1 Table 
 
 
 
ABSTRACT 
OBJECTIVE: To examine the influence of the glycemic index (GI) of foods consumed after evening-
exercise on post-prandial glycemia, metabolic and inflammatory markers, and nocturnal glycemic control 
in type 1 diabetes. RESEARCH DESIGN AND METHODS: On two evenings (~17:00 P.M.) ten male 
patients (27±1 years, HbA1c 6.7±0.2% / 49.9±2.4mmol/mol) administered a 25% rapid-acting insulin dose 
with a carbohydrate bolus 60 minutes prior to 45 minutes of treadmill running. At 60 minutes post-
exercise, patients administered a 50% rapid-acting insulin dose with one of two isoenergetic meals 
(1.0g.carbohdyrate.kg
-1
BM) matched for macronutrient content but of either low (LGI) or high (HGI) GI. 
At 180 minutes post-meal, LGI ingested a low GI snack, and HGI a high GI snack (0.4g.carbohdyrate.kg
-
1
BM), before returning home (~23:00 P.M.). Interval samples for blood glucose and lactate; plasma 
glucagon, epinephrine, IL-6 and TNF-α; and serum insulin, cortisol, NEFA, and β-hydroxybutyrate assay 
were obtained. Interstitial glucose was recorded for 20 hours post-laboratory attendance using continuous-
glucose monitoring. RESULTS: Following the post-exercise meal, HGI induced hyperglycemia in all 
patients (mean glucose [mean±SEM]: HGI 13.5±1.2 mmol.L
-1
) and marked increases in TNF-α and IL-6; 
whereas relative euglycemia was maintained with LGI (7.7±0.8 mmol.L
-1
; p<0.001) without 
inflammatory cytokine elevation. Both meal types protected all patients from early hypoglycemia. Over-
night glycemia was comparable with similar incidence of nocturnal hypoglycemia (HGI=4; LGI=4 
patients). CONCLUSIONS: Consuming low GI foods with a reduced rapid-acting insulin dose following 
evening exercise prevents post-prandial hyperglycemia and inflammation, and provides hypoglycemia 
protection for ~8 hours post-exercise; however, risk of late nocturnal hypoglycemia remains. 
 
 
 
 
 
There is a growing evidence base surrounding the wide range of health benefits from regular exercise, for 
type 1 diabetes patients (1). However, exercise remains the most frequently identified specific cause of 
severe hypoglycemia (2), the fear of which, remains the primary obstacle to patients wishing to engage in 
regular exercise (3). 
 
Strategies to combat exercise-induced hypoglycemia, such as manipulating exercise intensity (4), insulin 
dose and diet (5-7), or order in which different exercise types are undertaken (8), have predominantly 
been trialled for morning-time exercise (5-7). However, many individuals prefer to exercise in the 
evening due to study / work commitments or for social reasons. Unfortunately, exercise in the evening is 
associated with a greater risk of post-exercise hypoglycemia (4; 9), with low blood glucose levels likely 
to occur particularly nocturnally (2). Incorporation of evening exercise safely into the lives of people with 
type 1 diabetes is thus significantly hampered by the lack of appropriate evidence necessary for informed 
self-management strategies. 
 
We recently demonstrated that meal time insulin adjustment, specifically reducing the dose of rapid-
acting insulin before and after exercise, is vital to minimise risk of post-exercise hypoglycemia (5). 
However, there is currently little advice on optimal carbohydrate type for exercising patients with type 1 
diabetes (1). American Diabetes Association guidance focuses on the quantity rather than the composition 
of the carbohydrate to be consumed following exercise (10). Consumption of ~5 grams carbohydrate per 
kg body mass (BM) is typically recommended for moderate intensity exercise (11; 12), however, the food 
composition is also an important consideration, as the type of carbohydrate can exert a major influence on 
post-prandial glycemia in diabetes patients (13). Meals containing identical macronutrient compositions 
are digested and absorbed at varying rates producing a range of glycemic responses (14), with 
carbohydrate foodstuffs with a low glycaemic index (GI) eliciting a more gradual rise and fall in blood 
glucose compared to their high GI equivalents. Resultantly, more favorable post-prandial glycemic 
profiles have been shown following ingestion of low GI foods in patients with type 1 diabetes (15; 16).  
It may thus be possible to optimize post-exercise glycemia by manipulating the composition of foods 
consumed during this time. The protracted absorption rates of low GI foods may be beneficial for 
reducing post-prandial hyperglycemia. However, slower delivery of carbohydrate to post-exercise 
musculature, and potentially slower rates of muscle glycogen replenishment following exercise (17; 18), 
may increase the risk of post-exercise hypoglycemia (11; 19). Inversely, consuming high GI foods may 
promote accelerated muscle glycogen restoration (17; 18), reducing the incidence of post-exercise 
hypoglycemia (11; 19). However, the need to reduce insulin- to carbohydrate -ratio may be associated 
with post-prandial hyperglycemia following ingestion of high GI foodstuffs (15; 16), potentially leading 
to metabolic, hormonal, and inflammatory disturbances  (20-22).  
 
The aim of this study was to examine the influence of the glycemic index of the meal and subsequent 
bedtime snack consumed after evening-time exercise on post-prandial glycemia, metabolism and 
circulating inflammatory markers, in addition to nocturnal glycemic control in type 1 diabetes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESEARCH DESIGN AND METHODS 
Patients 
Eligibility criteria comprised of being aged between 18 and 35 years with a duration of diabetes >2 years 
upon enrollment, absence of diabetes-related complications including impaired awareness of 
hypoglycemia, and insulin therapy alone without any other medication. Ten males with type 1 diabetes 
were recruited ([mean±SEM] age 27±1 years, BMI 25.5±0.3, duration of diabetes 15±2 years, HbA1c 
6.7±0.2%, 49.9±2.4 mmol/mol,  ̇O2peak 52±1 ml.kg.min-1). All patients had been treated on a stable basal-
bolus regimen comprising of insulin aspart and once-daily insulin glargine for a minimum of 6 months. 
50% of patients were injecting insulin glargine in the morning, and 50% in the late evening / before bed. 
All patients undertook regular and consistent exercise (participating in aerobic-based exercise for at least 
30 minutes at a time, at least thrice weekly). All patients were familiar with carbohydrate counting, 
administering 1.0±0.1 units of insulin aspart per 10 g of carbohydrate.  
 
Following approval from the local National Health Service Research Ethics Committee, fully informed 
written consent was gained from all patients. Firstly, patients attended the Newcastle NIHR Clinical 
Research Facility exercise laboratory for a preliminary screening visit, as described by Campbell et al. 
(2013), before returning on three further occasions. On visit 1, peak cardiorespiratory parameters were 
collected during the completion of an incremental-maximal treadmill run protocol, as previously 
described (5; 6). Computer randomization then determined the sequence of the two subsequent 
experimental visits. 
 
Pre-laboratory phase 
CGM 
Patients were fitted with a continuous glucose monitor (CGM; Paradigm Veo, Medtronic diabetes, 
Northridge, CA, USA) using an Enlite sensor (Medtronic Minimed, Northridge, CA, USA), a minimum 
of 48 hours before attending the laboratory on each occasion. The Paradigm Veo (Medtronic Diabetes, 
Northridge, CA, USA) provides real time glucose profiles as part of an insulin pump. Patients did not use 
the continuous subcutaneous insulin infusion facility however, continuing their usual basal-bolus 
regimen. Glucose alerts were set at ≤3.5 and ≥16 mmol.L-1 during the pre-trial period. The high glucose 
alert was discontinued once patients left the laboratory after experimental trials. Sensors were placed in 
the postero-lateral abdominal region to minimize the physiological time lag between blood and interstitial 
glucose (23). Insertion site was replicated across visits. During sensor wear, patients performed a 
minimum of 4 daily capillary blood glucose tests (GlucoMen LX; Menarini Diagnostics, Berkshire, UK), 
entering all values into the CGM device for calibration. Capillary glucose values and not CGM data were 
used to inform self-administered insulin aspart doses. Downloaded data were retrospectively processed 
and analyzed using CareLink Veo Professional software (Medtronic Diabetes, Northridge, CA, USA). 
 
Diet and activity replication 
Over the 24 hours preceding main trial visits, patients replicated their diet (assessed using weighed dietary 
recording sheets) and were instructed to maintain their normal insulin regimen, with basal dose 
standardized (dose, injection site, and time of injection) across trials. During this time, patients used a 
pedometer (Omron Healthcare Europe B.V., Hoofddrorp, Holland) to record total step count. Avoidance 
of strenuous exercise was required in the previous 48 hours, with maintenance of similar activity patterns 
between trials, which were separated by at least 7 days. On the day of the trial, patients were provided 
with two standardized meals, a cereal-based breakfast (frosted flakes, semi-skimmed milk, and peaches) 
equating to 1.3g.carbohdyrate.kg
-1
BM (549±20 kcal) and a pasta-based lunch (pasta, tomato-based sauce, 
cheddar cheese, olive oil) equating to 1.3g.carbohdyrate.kg
-1
BM (968±35 kcal). Meal compositions were 
based on the habitual dietary patterns of those with type 1 diabetes, and current recommendations for 
exercise in diabetes patients (11; 12). When combined with meals provided in the laboratory during 
experimental trials, total dietary intake across the day was calculated to constitute ~5.0g.carbohdyrate.kg
-1
 
with a macronutrient content consisting of 77% carbohydrate, 12% fat and 11% protein (11; 12). 
 
Testing procedure 
Patients arrived at the laboratory in the late afternoon (~17:00 P.M.), replicating their start time across 
conditions. A 12-ml resting venous blood sample was taken of which 20μl was used for the immediate 
quantification of blood glucose and lactate (Biosen C-Line; EKF Diagnostic GmbH, London, UK) and 10 
μl analyzed for hemoglobin and hematocrit (Hemo Control; EKF Diagnostic GmbH, UK) used to correct 
for changes in plasma volume (24). The remaining sample was aliquoted equally into Lithium-heparin 
(Vacuette, Greiner Bio-One GmBH, Austria) and serum separation tubes (Vacuette, Greiner Bio-One 
GmBH, Austria) that were centrifuged for 15 minutes at 3000 rev.min
-1
 at 4˚C and stored at -80˚C for 
retrospective analysis of serum rapid-acting insulin analogue (Invitron Insulin Assay; Invitron, 
Monmouth, UK), cortisol (Parameter cortisol ELISA, R & D Systems, Roche Diagnostics, UK), non-
esterified fatty acids (NEFA; Non-esterified fatty acids colorimetric assay, Ranbut; Randox Laboratories, 
London, UK), and β-hydroxybutyrate (D-3-hydroxybutyrate kinetic enzymatic assay, Ranbut; Randox 
Laboratories, London, UK), and plasma glucagon (Glucagon EIA, Sigma-Aldrich, USA), adrenaline 
(CAT ELISA, Eagle Biosciences, UK), interleukin-6 (IL-6; Human IL-6 Quantikine ELISA, R & D 
Systems, Roche Diagnostics, UK) and tumour necrosis factor alpha (TNF-α; Human TNF-alpha 
Quantikine ELISA, R & D Systems, Roche Diagnostics, UK). The coefficient of variation was <10% for 
all biochemical analysis. 
 
Immediately after the resting sample, patients administered a 25% (2.0±0.1 units) dose (i.e., a 75% 
reduction) of insulin aspart into the abdomen with injection site standardized across trials, as equidistant 
between the iliac crest and naval, as currently recommended (5; 6; 25). Patients then consumed a pre-
exercise carbohydrate bolus (frosted flakes, semi-skimmed milk, and peaches) equating to 
1.0g.carbohdyrate.kg
-1
BM (423±15 kcal), within a five-minute period (5). 
 
Patients remained at rest for 60 minutes following consumption of the pre-exercise carbohydrate bolus. 
On 60 minutes, a blood sample was drawn immediately before commencing 45 minutes of treadmill 
(Woodway, Weil am Rhein, Germany) running at a speed calculated to elicit 70% of their  ̇O2peak, an 
intensity falling within recommendations of the American College of Sports Medicine (26) for exercising 
diabetes patients. Breath-by-breath respiratory parameters (MetaLyzer 3B; Cortex, Leipzig, Germany) 
and heart rate (S810; Polar, Kempele, Finland) were continuously recorded throughout exercise. 
Immediately following cessation of exercise, a blood sample was taken, with subsequent samples at 15, 
30 and 60 minutes post-exercise. At 60 minutes post-exercise patients administered a 50% (4.0±0.2 units) 
dose of insulin aspart into the contralateral abdominal site to the pre-exercise insulin aspart injection (5). 
With this, in a random and counter-balanced fashion, patients consumed one of two evening meals 
calculated to be of either low or high GI. Following this meal, patients remained rested with further 
periodic blood samples every 30 minutes for 180 minutes. All patients then consumed a trial-specific 
bedtime snack of either low or high GI. Patients could drink water ad libitum throughout. All patients 
received transport home and were instructed to continue their usual basal insulin dose and replicate 
sleeping patterns as best possible across trials. Hypoglycemia was defined as a blood or interstitial 
glucose concentration of ≤3.9 mmol.L-1, and hyperglycemia defined at glucose ≥8.0 mmol.L-1 (5).  
 
Meal compositions and bedtime snack 
All meals were pre-prepared by the research team and were composed of foodstuffs to elicit either a high 
or low GI response. We calculated the GI of each meal using methods described by Brouns et al (27) in 
10 non-diabetes control participants. Patients consuming the low GI evening meal subsequently 
consumed the low GI bedtime snack, and those patients consuming the high GI evening meal consumed 
the high GI snack. Both evening meals and bedtime snacks were matched for macronutrient content, 
palatability, and had negligible fiber content (see supplemental table 1). Bedtime snacks equated to 
0.4g.carbohdyrate.kg
-1
BM (28).  
 
Calculation of substrate oxidation 
During exercise, at fifteen minutes before the post-exercise meal, and at 45, 105, and 165 minutes 
following the post-exercise meal, expired gases were analyzed (MetaLyzer 3B; Cortex, Leipzig, 
Germany). Substrate oxidation rates and energy expenditure were determined from oxygen consumption 
and carbon dioxide production values using stoichiometric equations (29).  
 
Post-laboratory period 
While wearing CGM, patients continued to self-record and replicate their diet throughout both trials using 
the weighed food diary. Patients were required to report additional carbohydrate ingestion and 
administration of corrective doses of insulin aspart. Patients were instructed to keep meal times, as well as 
insulin aspart and insulin and glargine doses consistent across trials. 
 
Data analysis 
Statistical analysis was performed using PASW Statistics software (IBM PASW version 18; IBM, 
Armonk, NY, USA). A repeated-measures ANOVA on two levels (condition and time) was conducted, 
with Bonferroni corrected pair-wise comparisons and paired samples t-test used to examine time and 
condition effects, respectively.  Statistical significance was accepted at p<0.05. Area under the curve was 
calculated using the methods described by Wolever and Jenkins (30). 
 
 
 
 
 
 
 
 
 
RESULTS 
Pre-laboratory phase 
Glycemic control was comparable over the 24 hours prior to patients’ arrival at the laboratory for both 
experimental trials, (CGM mean glucose: HGI 7.9±0.7; LGI 7.9±0.7 mmol.L
-1
, p=0.465; and total 
interstitial glucose area under the curve: HGI 11277±1069; LGI 10971±1126 mmol.L
-1
.min
-1
, p=0.215). 
Dietary intake was also similar during the 24 hours before both trials. There were no differences in total 
energy consumed (HGI 2143±673; LGI 2358±668 kcal, p=0.508), with similar contribution from 
carbohydrate (HGI 51±3; LGI 46±3 %, p=0.896), fat (HGI 30±3; LGI 32±4 %, p=0.301) and protein 
(HGI 20±2; LGI 22±3 %, p=0.556). The total amount of insulin administered (HGI 26±4; LGI 26±4 
units, p=0.609) and levels of activity (HGI 6949±105; LGI 7041±118 steps, p=0.372) were comparable 
over the 24 hours before each trial. 
 
Laboratory phase 
There was a significant time effect (p<0.001), condition effect (p=0.05), and a significant condition*time 
interaction for absolute blood glucose concentrations (p<0.001; Figure 1). Blood glucose values were 
comparable before the standardized pre-exercise carbohydrate bolus / insulin injection and after the 1 
hour pre-exercise rest period during both experimental trials (Figure 1). Serum insulin and all other 
hormones and metabolites were similar at rest and immediately before exercise (p>0.05; Figure 2A-B, 
Table 1).  
 
Patients exercised at a similar intensity (% ̇O2peak: HGI 77±0.03; LGI 74±0.03, p=0.352; and HRpeak: 
HGI 80±2; LGI 79±3, p=0.631). Patients ran at a velocity of 10.10.3 km.hr-1, completing 7.60.2 km 
and expending 71848 kcal. Similar peak lactates were elicited immediately post-exercise (HGI 4.1±0.8; 
LGI 4.2±0.5 mmol.L
-1
, p=0.137; Table 1). Exercise induced a similar decrease in blood glucose from pre-
exercise concentrations (HGI -5.4±0.7; LGI -6.8±0.5 mmol.L
-1
; p=0.733, Figure 1), such that 
immediately following the cessation of exercise blood glucose were comparable to baseline under both 
conditions (p=0.304; Figure 1). There were no incidences of hypoglycemia during exercise, with all 
patients completing the exercise protocol on both occasions. Immediately before the post-exercise meal, 
serum insulin concentrations were similar to resting concentrations (p>0.05; Table 1), as were all other 
hormones, metabolites and cytokines (p>0.05; Figure 2A-C and Table 1). 
 
Post-exercise intervention 
Serum insulin peaked similarly at 60 minutes following the post-exercise meal, before declining under 
both conditions, with concentrations returning to resting values at 180 minutes (p>0.05; Table 1). Blood 
glucose levels increased over the 180 minutes after both post-exercise meals, but this was significantly 
attenuated under LGI in comparison to HGI (p<0.05; Figure 1). Over this time, all patients were 
protected from hypoglycemia under both conditions. However, all patients were exposed to 
hyperglycemia after the HGI meal, whereas this was limited to 4 patients after LGI. Moreover, 
hyperglycemia was less pronounced (mean peak blood glucose: LGI 8.8±1.0 vs. HGI 15.9±1.2 mmol.L
-
1
), and tended to be only transient (time spent hyperglycemic: LGI 81±26 vs. HGI 165±15 minutes) 
following the LGI meal. On leaving the laboratory, blood glucose remained significantly greater under 
after the HGI meal (HGI 12.7±1.5; LGI 7.5±2.6 mmol.L
-1
, p=0.004; Figure 1), with more patients 
leaving the laboratory hyperglycemic (HGI n = 9, LGI n = 4). 
 
Counter-regulatory hormonal and metabolic responses are presented in Table 1, with inflammatory 
cytokine and -hydroxybutyrate responses in Figure 2A-C. There were no differences in serum -
hydroxybutyrate concentrations between the two experimental trials (p>0.05; Figure 2A). Following the 
post-exercise meal, IL-6 and TNF-α concentrations significantly increased from rest and pre-meal 
concentrations in the HGI trial, and were significantly greater than LGI during the post-prandial period 
(p<0.05; Figure 2B-C). During this period, concentrations in the LGI trial were significantly lower than 
baseline measures (p<0.05; Figure 2B-C).  
 There were no differences in substrate oxidation responses during the post-exercise meal period of both 
trials, with carbohydrate (HGI 14.5±2.6; LGI 14.7±2.7 g.carbohydrate.hr
-1
, p=0.927) and lipid (HGI 
3.0±0.9; LGI 3.1±0.9 g.lipid.hr
-1
, p=0.809) oxidation rates similar.  
 
Post-laboratory phase 
Late Evening 
After leaving the laboratory, interstitial glucose concentrations in the HGI trial were significantly greater 
than LGI in the time before sleep (Figure 3), with individualized mean peak interstitial glucose higher 
(HGI 18.3±1.1; LGI 13.9±0.8 mmol.L
-1
, p=0.009).  
 
Nocturnal glycemic control 
During sleep, falling glucose levels were evident under both conditions such that concentrations became 
comparable 8 hours after exercise (p>0.05; Figure 3). Five patients during the LGI trial and 5 during the 
HGI trial were exposed to hypoglycemia, all of which occurred nocturnally. Some patients experienced 
multiple bouts of hypoglycemia, (HGI n = 10, LGI n = 8). Mean interstitial glucose nadir was similar 
between both conditions (HGI 3.6±0.4; LGI 3.4±0.3, p=0.650), as was time spent in hypoglycemic 
(p=0.569), euglycemic (p=0.705), and hyperglycemic (p=0.765) ranges (Figure 3).  
 
Next day glycemic responses 
On waking, interstitial glucose levels were comparable (HGI 8.5±0.9; LGI 8.3±0.9 mmol.L
-1
, p=0.614; 
Figure 3), and glycemia remained similar between conditions for the remainder of the 24 hour post-
exercise window (p>0.05). 
 
During the post-laboratory period, total energy consumed (HGI 719±256, LGI 686±289 kcal, p=0.774), 
with contribution from carbohydrate (HGI 72±5; LGI 64±8 %, p=0.767), fat (HGI 20±5; LGI 22±7 %, 
p=0.834), and protein (HGI 8±3; LGI 14±6 %, p=0.548) similar between conditions. Activity patterns for 
24 hours after exercise were comparable (HGI 6086±94; LGI 6478±112 steps, p=0.369). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSIONS 
The aim of this study was to determine whether manipulating the glycemic index of foods consumed 
following evening-time exercise could modulate post-prandial glycemia and metabolism, to provide 
protection from post-exercise hyperglycemia and hypoglycemia in patients with type 1 diabetes. To our 
knowledge, this is the first study to show that consumption of low glycemic index foodstuffs, under 
conditions of reduced rapid-acting insulin dose following evening exercise, improves post-prandial 
glycemia, reducing hyperglycemia and concentrations of circulating inflammatory markers, in 
combination with protection from hypoglycemia for approximately 8 hours after exercise. However, 
beyond this time risk of late-onset nocturnal hypoglycemia persists regardless of the glycemic index of 
the post-exercise meal and bedtime snack.  
 
We recently demonstrated the importance of reducing the rapid-acting insulin dose administered with the 
meal after, as well as before exercise to extend the period of protection from post-exercise hypoglycemia 
(5). Now we demonstrate that under these conditions, the composition of the post-exercise meal has an 
important role for modulating post-prandial glycemia. Blood glucose concentrations with the HGI post-
exercise meal and snack were significantly greater than those with LGI, consequently exposing all 
patients in the former condition to hyperglycemia during the laboratory observation period. Conversely, 
the incidence of hyperglycemia was reduced by 60% after LGI (LGI = 40% vs. HGI = 100%). Indeed, in 
those patients affected, hyperglycemia was less pronounced and tended to be only transient and short 
lasting after LGI meals. Despite clear post-prandial differences in glycemia between the two conditions, 
all patients were still protected from hypoglycemia during their time in the laboratory. Presently, there are 
relatively few dietary guidelines to assist individuals with type 1 diabetes in managing post-exercise 
glycemia. However, we have shown that by consuming a low glycemic index post-exercise meal, post-
prandial hyperglycemia can be reduced, without exposure to hypoglycemia. This is an important 
observation because the aim of diabetes management is to normalize blood glucose concentrations (31), 
especially when incorporating exercise into the lives of patients (1).  
Given the potential for such large differences in post-prandial glycemia with this strategy, we examined 
this impact on metabolic, hormonal and inflammatory measures. This is important, as regular exposure to 
metabolic, hormonal or inflammatory disturbances could significantly influence long-term diabetes-
related complications in regularly exercising patients (25). Here we show that meal GI has significant 
implications for post-prandial circulating inflammatory markers; specifically, we demonstrate for the first 
time, under non-clamp techniques and replicating free-living conditions, that the inflammatory cytokines 
TNF-α and IL-6 were dramatically increased following a high GI meal. An otherwise comparable low GI 
meal completely prevented rises in these inflammatory cytokines. The clinical relevance of these findings 
should not be underestimated, as offsetting hyperglycemia and inflammation is important for preventing 
early pathogenetic diabetes-related complications (22). Additionally, β-hydroxybutyrate concentrations 
did not significantly rise under either condition (Figure 2 A), remaining similar to pre-meal and resting 
concentrations. Basal insulin dose remained unchanged, and despite a reduction in rapid-acting insulin 
dose, circulating insulin concentrations remained sufficient for a suppression in β-hydroxybutyrate 
production (32) and to drive ketone body disposal (33). Concentrations during both trial conditions were 
well below those levels deemed clinically significant (>1.0 mmol.L
-1
)(21).  
 
When exercise is performed in the evening, consumption of a carbohydrate-based snack before bed is 
recommended (28). Blood glucose was typically within the euglycemic range prior to the consumption of 
the bedtime snack following LGI, but still hyperglycemic following HGI (LGI ~7.5 vs. HGI ~12.2 
mmol.L
-1
). Outside formal studies, patients within normal blood glucose ranges before bed often choose 
to raise blood glucose concentrations by consuming a carbohydrate-based snack (28) due to fear of 
nocturnal hypoglycemia (34). However, patients in the hyperglycemic range before bed may be tempted 
to administer corrective insulin units, which, in an exercise-induced insulin sensitized state (35; 36), is 
likely to cause a rapid fall in glucose during the night. Avoidance of the bedtime snack, and hence 
missing a valuable source of carbohydrate before sleep, is likely to exacerbate the risk of nocturnal 
hypoglycemia. Despite large differences in blood glucose concentrations before bed following HGI and 
LGI in the current study, levels fell under both conditions becoming comparable 3 hours after consuming 
the bedtime snacks, with similar rates of nocturnal hypoglycemia thereafter. This indicates patients are at 
risk of late-onset nocturnal hypoglycemia despite the consumption of a bedtime snack, with predicted 
nadir more than 8 hours post-exercise (5; 9), and regardless of the GI of the snack or blood glucose levels 
before bed. 
 
So that we could investigate the impact of the GI of the evening foodstuffs, patients consumed enough 
carbohydrate (consuming 2.6 g.carbohdyrate.kg
-1
 during the evening) to cover the cost of the exercise 
bout, with patients utilizing ~1.7 g.carbohdyrate.kg
-1 
in total during exercise, and with total daily 
carbohydrate intake matching current recommendations (~5.0g.carbohdyrate.kg
-1
; (11; 12), thus 
establishing a positive carbohydrate balance. Despite consuming sufficient carbohydrate for the recovery 
of muscle glycogen post-exercise, and perhaps even consuming more carbohydrate than is typical, 
hypoglycemia was still encountered late after exercise in the early hours of the morning. These findings 
direct attention towards the role of basal insulin administration in avoiding nocturnal hypoglycemia after 
evening exercise. Considering once daily insulin glargine administration is associated with a glucose 
nadir 4-14 hours after administration (37; 38), not only basal insulin dose but also the timing of 
administration may be of particular importance.  
 
This study shows for the first time that consuming low glycemic index foods, in tandem with reduced 
rapid-acting insulin dose, following evening exercise can play an important role in normalizing glycemia, 
preventing post-prandial hyperglycemia and inflammation, whilst protecting patients from post-exercise 
hypoglycemia for up to 8 hours. The clinical utility of these findings is clear, as foodstuffs which are part 
of a patients habitual diet can be easily exchanged with those that offer the same macronutrient content 
but are of a low GI (e.g. substituting particular types of breads, strains of rice, pastas and potatoes), 
facilitating more desirable post-prandial glycemic responses. However, it does not seem that carbohydrate 
type, nor total carbohydrate intake alone, are factors in the development of late-onset hypoglycemia, as 
patients may still be exposed to nocturnal hypoglycemia following evening-time exercise. Future research 
is planned focusing on basal insulin adjustment to determine whether late-onset nocturnal hypoglycemia 
following evening-time exercise can be avoided, whilst harnessing the benefits of consuming low GI 
foodstuffs, with a reduced rapid-acting insulin dose, during the post-exercise period. 
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Table 1. Serum Insulin counter-regulatory hormonal and blood metabolite responses to post-exercise meals of differing glycemic index  
  ANOVA p 
 Rest 60 Exercise 0 15 30 Pre-Meal 30 60 90 120 150 180 T T*C 
Serum  
Insulin      
(pmol.L-1) 
HGI 126±17 137±20  201±40† 138±22 128±21 105±15 179±34‡ 180±32‡ 143±21‡ 127±22‡ 95±17 94±18 <0.001 =0.992 
LGI 124±18 150±23 
 203±38† 137±23 125±20 102±15 172±35‡ 174±34‡ 144±20‡ 126±16‡ 105±17 98±17   
Plasma 
Glucagon 
(pg.mL-1) 
HGI 730±99 591±72†  682±68 760±83 768±94 833±117 953±155† 922±154† 872±145† 798±141 690±100‡ 669±101‡ <0.001 =0.306 
LGI 733±130 611±75† 
 
658±68 792±82 818±100 816±125 947±170†‡ 937±159†‡ 907±149† 862±141 806±120 840±139   
Plasma 
Adrenaline       
(nmol.L-1) 
HGI 0.09±0.01 0.15±0.03  0.55±0.10† 0.35±0.11† 0.15±0.03 0.15±0.04 0.17±0.02 0.16±0.03 0.11±0.04 0.09±0.02 0.11±0.03 0.08±0.02 =0.013 =0.497 
LGI 0.08±0.02 0.15±0.02 
 
0.54±0.12† 0.28±0.10† 0.14±0.04 0.14±0.04 0.15±0.02 0.13±0.03 0.11±0.02 0.11±0.02 0.10±0.02 0.07±0.02   
Serum  
Cortisol       
(nmol.L-1) 
HGI 0.17±0.03 0.18±0.02  0.28±0.02† 0.33±0.04† 0.24±0.03† 0.19±0.02 0.14±0.02 0.14±0.02 0.13±0.02‡ 0.11±0.01†‡ 0.08±0.01†‡ 0.08±0.01†‡ <0.001 =0.099 
LGI 0.17±0.03 0.15±0.02 
 
0.24±0.03† 0.32±0.05† 0.23±0.04† 0.18±0.03 0.13±0.02‡ 0.12±0.02‡ 0.10±0.01†‡ 0.10±0.01‡ 0.10±0.01‡ 0.09±0.01‡   
Serum  
NEFA 
(mmol.L-1) 
HGI 0.18±0.05 0.12±0.03  0.25±0.06 0.35±0.06† 0.43±0.11† 0.53±0.15† 0.37±0.07 0.24±0.06‡ 0.24±0.07‡ 0.27±0.11‡ 0.27±0.09‡ 0.35±0.13 =0.011 =0.514 
LGI 0.27±0.07 0.18±0.03 
 
0.27±0.07 0.34±0.07† 0.33±0.07 0.39±0.10† 0.39±0.10† 0.27±0.07 0.24±0.05 0.24±0.05 0.27±0.05 0.30±0.05   
Blood  
Lactate 
(mmol.L-1) 
HGI 1.0±0.2 1.1±0.3  4.1±0.8† 2.1±0.5† 1.3±0.3 1.0±0.3 0.7±0.2 0.9±0.2 0.8±0.1 0.7±0.2 0.5±0.1 0.4±0.1† =0.001 =0.129 
LGI 0.9±0.2 1.0±0.2 
 
4.2±0.5† 1.7±0.3 1.2±0.3 1.±0.2 0.8±0.2† 1.0±0.2 1.1±0.2 1.2±0.2‡ 0.6±0.2 0.5±0.2   
NOTE: Data presented as mean  SEM. Test meal and insulin were administered immediately following rest and pre-meal sample points. * indicates significantly different between conditions (p ≤ 0.05). † 
indicates significantly different from rest. ‡ indicates significantly different from pre-meal. Exercise commenced 60 minutes after rest. T = Time, C = Condition. 
 Figure 1. (A) Time-course changes in blood glucose from rest, during exercise and over the 3 hours post-
exercise. Data are presented as mean ± SEM error bars. Squares = LGI, diamonds = HGI. Transparent 
markers indicate significant difference from pre-meal concentrations (p≤0.05). * indicates significant 
difference between conditions (p≤0.05). Thatched area indicates exercise; vertical dashed line indicates post-
exercise meal intervention. NOTE: Test meal and insulin were administered immediately following rest and 60 
minutes post-exercise sample points. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. (A) Time-course changes in serum β-hydroxybutyrate, (B) plasma IL-6 and (C) plasma TNF-α. 
Data are presented as mean ± SEM error bars. Squares = LGI, diamonds = HGI. Transparent markers indicate 
significant difference from pre-meal concentrations (p≤0.05). * indicates significant difference between 
conditions (p≤0.05). Thatched area indicates exercise; vertical dashed line indicates post-exercise meal 
intervention. NOTE: Test meal and insulin were administered immediately following rest and 60 minutes post-
exercise sample points. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Time-course changes in interstitial glucose throughout the post-laboratory period. Data are 
presented as mean ± SEM. Red trace = HGI, blue trace = LGI.* indicates interstitial glucose area under the 
curve is significantly different between conditions (p≤0.05). Vertical dashed lines indicates nocturnal or day-
time periods. End of nocturnal period indicates when patients awoke. 
 
